抗原-话题@MedSci

#抗原#

244篇内容 | 4320人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1623262, encodeId=a9251623262f3, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=PLoS One：前列腺特异性膜抗原（PSMA）在非小细胞肺癌中的表达, objectType=article, longId=118249, objectId=77211182498e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77211182498e, replyNumber=0, likeNumber=64, createdTime=2017-11-02, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77211182498e, moduleTitle=PLoS One：前列腺特异性膜抗原（PSMA）在非小细胞肺癌中的表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77211182498e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623261, encodeId=42c11623261ae, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=CLIN CANCER RES ：抗原呈递后BTLA对CD8+T细胞具有多种作用, objectType=article, longId=118038, objectId=343d11803809, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=343d11803809, replyNumber=0, likeNumber=116, createdTime=2017-10-31, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=343d11803809, moduleTitle=CLIN CANCER RES ：抗原呈递后BTLA对CD8+T细胞具有多种作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=343d11803809)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623260, encodeId=d4451623260c7, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=乙肝防治须重视乙肝表面抗原突变隐患, objectType=article, longId=117707, objectId=bd8611e70716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd8611e70716, replyNumber=0, likeNumber=74, createdTime=2017-10-28, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd8611e70716, moduleTitle=乙肝防治须重视乙肝表面抗原突变隐患, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd8611e70716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623259, encodeId=6bec1623259bd, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Blood：靶向CD19的嵌合抗原受体修饰的T细胞免疫疗法的感染性并发症研究。, objectType=article, longId=116944, objectId=9e6111694445, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e6111694445, replyNumber=0, likeNumber=78, createdTime=2017-10-22, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e6111694445, moduleTitle=Blood：靶向CD19的嵌合抗原受体修饰的T细胞免疫疗法的感染性并发症研究。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e6111694445)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623258, encodeId=23611623258e4, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=CLIN CHEM：表面等离子体共振是对细胞外囊泡抗原分析一项敏感方法, objectType=article, longId=116902, objectId=a69a1169029e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a69a1169029e, replyNumber=0, likeNumber=80, createdTime=2017-10-21, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a69a1169029e, moduleTitle=CLIN CHEM：表面等离子体共振是对细胞外囊泡抗原分析一项敏感方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a69a1169029e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623257, encodeId=3113162325e1c, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Science：两篇论文从结构上揭示细胞**地呈递抗原机制, objectType=article, longId=116403, objectId=108811640380, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=108811640380, replyNumber=0, likeNumber=79, createdTime=2017-10-18, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=108811640380, moduleTitle=Science：两篇论文从结构上揭示细胞**地呈递抗原机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=108811640380)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623256, encodeId=3a40162325657, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Urol：前列腺癌发生率和前列腺特异抗原筛选流行度分析, objectType=article, longId=116154, objectId=5333116154e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5333116154e5, replyNumber=0, likeNumber=67, createdTime=2017-10-15, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5333116154e5, moduleTitle=J Urol：前列腺癌发生率和前列腺特异抗原筛选流行度分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5333116154e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623255, encodeId=b7cb1623255f5, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Diabetologia：无缺失癌胚抗原相关细胞粘附分子2的雄性小鼠中年龄依赖性胰岛素抵抗如何？, objectType=article, longId=114998, objectId=e85211499869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e85211499869, replyNumber=0, likeNumber=115, createdTime=2017-10-02, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e85211499869, moduleTitle=Diabetologia：无缺失癌胚抗原相关细胞粘附分子2的雄性小鼠中年龄依赖性胰岛素抵抗如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e85211499869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623254, encodeId=869416232540c, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Blood：嵌合抗原受体（CARs）为多发性骨髓瘤带来新的治疗前景。, objectType=article, longId=113425, objectId=4e18113425e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e18113425e4, replyNumber=0, likeNumber=98, createdTime=2017-09-22, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e18113425e4, moduleTitle=Blood：嵌合抗原受体（CARs）为多发性骨髓瘤带来新的治疗前景。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e18113425e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623253, encodeId=db6a162325387, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Diabetic Med：成人糖尿病患者的谷氨酸脱羧酶和胰岛抗原2抗体谱, objectType=article, longId=111586, objectId=dc5c111586f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc5c111586f1, replyNumber=0, likeNumber=58, createdTime=2017-09-02, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc5c111586f1, moduleTitle=Diabetic Med：成人糖尿病患者的谷氨酸脱羧酶和胰岛抗原2抗体谱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc5c111586f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623252, encodeId=fc921623252e3, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Cancer Immunol Immunother：DNA编码的抗前列腺特异膜抗原单克隆抗体的新的前列腺癌免疫疗法, objectType=article, longId=110926, objectId=a84a11092689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a84a11092689, replyNumber=0, likeNumber=92, createdTime=2017-08-27, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a84a11092689, moduleTitle=Cancer Immunol Immunother：DNA编码的抗前列腺特异膜抗原单克隆抗体的新的前列腺癌免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a84a11092689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623251, encodeId=234c16232518b, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Sci Rep：不同人类疫苗免疫佐剂对各种病原体产生的独特抗原无关免疫特性, objectType=article, longId=107231, objectId=73b310e23141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73b310e23141, replyNumber=0, likeNumber=73, createdTime=2017-08-02, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73b310e23141, moduleTitle=Sci Rep：不同人类疫苗免疫佐剂对各种病原体产生的独特抗原无关免疫特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73b310e23141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623250, encodeId=45a11623250cf, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=疫苗制备过程中针对抗原筛选标准、佐剂选择、效价验证及临床应用时机等问题进行讨论。, objectType=article, longId=106950, objectId=4e8a106950e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e8a106950e1, replyNumber=0, likeNumber=54, createdTime=2017-07-29, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e8a106950e1, moduleTitle=疫苗制备过程中针对抗原筛选标准、佐剂选择、效价验证及临床应用时机等问题进行讨论。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e8a106950e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623249, encodeId=c1c01623249f7, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, objectType=article, longId=106882, objectId=61e910688226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61e910688226, replyNumber=0, likeNumber=23, createdTime=2017-07-28, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61e910688226, moduleTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61e910688226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623248, encodeId=0b011623248ef, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J INFECTION：纯化沙门氏菌伤寒蛋白抗原对急性伤寒血清学诊断的评估, objectType=article, longId=106199, objectId=207d1061998b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=207d1061998b, replyNumber=0, likeNumber=48, createdTime=2017-07-23, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=207d1061998b, moduleTitle=J INFECTION：纯化沙门氏菌伤寒蛋白抗原对急性伤寒血清学诊断的评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=207d1061998b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623247, encodeId=3864162324e63, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Viral Hepat：乙肝表面抗原定量能否预测E基因型患者的疾病严重程度？, objectType=article, longId=105739, objectId=669e105e3924, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=669e105e3924, replyNumber=0, likeNumber=78, createdTime=2017-07-18, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=669e105e3924, moduleTitle=J Viral Hepat：乙肝表面抗原定量能否预测E基因型患者的疾病严重程度？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=669e105e3924)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623246, encodeId=3dc216232464c, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Lancet Oncol：插入和缺失突变驱动的肿瘤特异性抗原以及其免疫特征, objectType=article, longId=105121, objectId=7755105121e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7755105121e7, replyNumber=0, likeNumber=68, createdTime=2017-07-11, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7755105121e7, moduleTitle=Lancet Oncol：插入和缺失突变驱动的肿瘤特异性抗原以及其免疫特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7755105121e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623245, encodeId=6b3e1623245f1, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Lancet oncol：基因突变所导致肿瘤特异性抗原和免疫表型, objectType=article, longId=105005, objectId=003c105005d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=003c105005d8, replyNumber=0, likeNumber=80, createdTime=2017-07-10, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=003c105005d8, moduleTitle=Lancet oncol：基因突变所导致肿瘤特异性抗原和免疫表型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=003c105005d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623244, encodeId=7cb2162324457, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Nature：个性化新抗原疫苗引发强烈抗肿瘤反应,攻克癌症治疗两大障碍！, objectType=article, longId=104787, objectId=935a104e87a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=935a104e87a6, replyNumber=0, likeNumber=80, createdTime=2017-07-08, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=935a104e87a6, moduleTitle=Nature：个性化新抗原疫苗引发强烈抗肿瘤反应,攻克癌症治疗两大障碍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=935a104e87a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623243, encodeId=ac5c16232439c, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Nature：个性化新抗原疫苗引发强烈抗肿瘤反应,攻克癌症治疗两大障碍！, objectType=article, longId=104784, objectId=aeba104e848a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aeba104e848a, replyNumber=0, likeNumber=57, createdTime=2017-07-08, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aeba104e848a, moduleTitle=Nature：个性化新抗原疫苗引发强烈抗肿瘤反应,攻克癌症治疗两大障碍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aeba104e848a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗原

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

PLoS One：前列腺特异性膜抗原（PSMA）在非小细胞肺癌中的表达

2017-11-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

CLIN CANCER RES ：抗原呈递后BTLA对CD8+T细胞具有多种作用

2017-10-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

乙肝防治须重视乙肝表面抗原突变隐患

2017-10-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Blood：靶向CD19的嵌合抗原受体修饰的T细胞免疫疗法的感染性并发症研究。

2017-10-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

CLIN CHEM：表面等离子体共振是对细胞外囊泡抗原分析一项敏感方法

2017-10-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Science：两篇论文从结构上揭示细胞**地呈递抗原机制

2017-10-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Urol：前列腺癌发生率和前列腺特异抗原筛选流行度分析

2017-10-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Diabetologia：无缺失癌胚抗原相关细胞粘附分子2的雄性小鼠中年龄依赖性胰岛素抵抗如何？

2017-10-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Blood：嵌合抗原受体（CARs）为多发性骨髓瘤带来新的治疗前景。

2017-09-22

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Diabetic Med：成人糖尿病患者的谷氨酸脱羧酶和胰岛抗原2抗体谱

2017-09-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Cancer Immunol Immunother：DNA编码的抗前列腺特异膜抗原单克隆抗体的新的前列腺癌免疫疗法

2017-08-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Sci Rep：不同人类疫苗免疫佐剂对各种病原体产生的独特抗原无关免疫特性

2017-08-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

疫苗制备过程中针对抗原筛选标准、佐剂选择、效价验证及临床应用时机等问题进行讨论。

2017-07-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究

2017-07-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J INFECTION：纯化沙门氏菌伤寒蛋白抗原对急性伤寒血清学诊断的评估

2017-07-23

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Viral Hepat：乙肝表面抗原定量能否预测E基因型患者的疾病严重程度？

2017-07-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Lancet Oncol：插入和缺失突变驱动的肿瘤特异性抗原以及其免疫特征

2017-07-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Lancet oncol：基因突变所导致肿瘤特异性抗原和免疫表型

2017-07-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Nature：个性化新抗原疫苗引发强烈抗肿瘤反应,攻克癌症治疗两大障碍！

2017-07-08

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Nature：个性化新抗原疫苗引发强烈抗肿瘤反应,攻克癌症治疗两大障碍！

2017-07-08

科室
- - 订阅+
  - 更多科室
工具
服务